Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension
about
Antioxidant supplements for preventing gastrointestinal cancersAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesAntioxidant supplements for preventing gastrointestinal cancersHuman ACE and bradykinin B2 receptors form a complex at the plasma membraneAntioxidants in Translational MedicineHypertension management and microvascular insulin resistance in diabetesCocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension.Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization.Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitusCombination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionThe Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderlyAngiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink.Evidence-based approach for managing hypertension in type 2 diabetes.Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertensionMortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialThe relationship between blood pressure and cognitive function.Primary prevention of heart failure.Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes.Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study).Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohortB7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.From mitochondria to disease: role of the renin-angiotensin system.Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.Type 2 diabetes mellitus and heart failure.Blood pressure control and cardiovascular risk reduction.Results of the ONTARGET and TRANSCEND studies: an update and discussion.Treatment strategies for the prevention of heart failureImpact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.Recent changes in the landscape of combination RAS blockade.Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndromeAngiotensin II blockade: a strategy to slow ageing by protecting mitochondria?Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunities.Vascular memory: can we broaden the concept of the metabolic memory?Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.Hypertension and Stroke: Epidemiological Aspects and Clinical Evaluation.Clinical significance of 'cardiometabolic memory': a systematic review of randomized controlled trials.
P2860
Q24242191-0AC4FB40-BE7F-409E-92AF-97ECFC5205A9Q24242944-72FB2BF6-DC81-4C19-BBA5-83E4F375062BQ24245704-01C6D5D1-4A38-45AB-A903-0D7515553414Q24310586-B633993C-2F4A-49A0-B513-9C12A80BC634Q28394550-0907F706-1A51-440A-8A68-FC5D8B652B4FQ30433501-0D18EFD5-04BC-4B48-A7F4-A10F15DA44A9Q30434226-AB9B5E35-56DB-43E8-BAFD-5CB86324F16BQ30444650-5E9A9E7E-733E-40CC-BD5A-39CD192185F7Q33269618-E909CDE6-1978-4418-AA03-4DD070CCF38FQ34179121-088A3EEC-1094-471D-8714-B0D2E55F3563Q34231611-5602B988-0450-4555-8A6B-AA8B79EC678FQ34297130-23ED1806-5909-48EB-8098-25D7003A1E89Q34386587-AD4A4066-089A-4CCD-A579-E9FBB1B90A90Q35023755-FFBB28CA-B067-4667-9C8B-5FEE5D8A5D44Q35210531-525DFFFE-410D-46E8-B392-7D5CE7A733E6Q35670580-AB2BE97F-6A1E-4943-BEF1-AE4E8112E0F1Q35681739-A702B1EB-209A-4D10-8A45-DB525D60D433Q35893991-594CF632-C08C-40A9-AEFA-EE7B82B70403Q36200030-58220D86-4267-4247-9ED9-C2DBCD30F33AQ36280369-68EF83F6-79B1-4E94-9A6A-81C1AA610FFDQ36487191-AF1C0EB0-A0B3-44E2-8516-D0763A291A62Q36536294-219C576F-C283-42E7-B396-46C69C9AF1B4Q36572172-F86DC625-F72B-47A8-B0F8-C82366EA4480Q36746102-926F7683-F7B7-486D-96F9-40538250E22EQ36929305-2E61EB2A-DB91-413E-A297-95DC7408E0E0Q36986398-3FF6B505-0479-4D9A-8B2F-C761FC042F78Q37069176-94A0BDAF-2403-46CD-A35C-30E4FF531E12Q37135836-6DADDE7E-57E9-4DBC-866E-69D14D11E1FBQ37167526-5B129221-5C21-4F3F-A875-ECD4392F8541Q37297198-9A4C001E-6DB8-4AEC-AAFA-9013F680B0A7Q37486525-C6E3BAF4-3AFE-4619-870E-E13D9B2EBE18Q37629835-0B54A3C2-5979-482C-BFC5-72B3EF4E1F1CQ37643052-9A61D29C-7CAC-473D-8C24-F29D611327ACQ37785713-E2946393-D074-4ECD-ADBB-44CCB3619848Q37939271-DA6C9DC8-E814-480B-83B5-0926A27D6319Q38006502-920720FE-6ECE-45F2-A4B1-D02C19FEE6A9Q38183131-6B54738E-269C-4C5C-87A8-DAC369EB31D7Q38272734-1C9E71F9-18A1-40A6-9696-8827AAC30B71Q38544562-4FDA1ACC-820E-49CF-A61B-C8212BF2F8B6Q39094213-D5637D2F-B5F3-4A25-9FBE-FC03017A6E68
P2860
Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Long-term effects of ramipril ...... ts of the HOPE study extension
@ast
Long-term effects of ramipril ...... ts of the HOPE study extension
@en
Long-term effects of ramipril ...... ts of the HOPE study extension
@nl
type
label
Long-term effects of ramipril ...... ts of the HOPE study extension
@ast
Long-term effects of ramipril ...... ts of the HOPE study extension
@en
Long-term effects of ramipril ...... ts of the HOPE study extension
@nl
prefLabel
Long-term effects of ramipril ...... ts of the HOPE study extension
@ast
Long-term effects of ramipril ...... ts of the HOPE study extension
@en
Long-term effects of ramipril ...... ts of the HOPE study extension
@nl
P2093
P1433
P1476
Long-term effects of ramipril ...... ts of the HOPE study extension
@en
P2093
Gilles R Dagenais
J Malcolm O Arnold
Jackie Bosch
P304
P356
10.1161/CIRCULATIONAHA.105.548461
P407
P577
2005-08-30T00:00:00Z